Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The CFTR-mediated protein secretion defect: pharmacological correction.

M A McPherson1, M M Pereira, D Russell

  • 1Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK.

Pflugers Archiv : European Journal of Physiology
|February 15, 2002
PubMed
Summary

Researchers explored pharmacological methods to fix defective protein secretion in cystic fibrosis (CF) airway cells. Certain compounds corrected CFTR function, offering potential for new CF therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Early Trial-Based Cost-Effectiveness Analysis of Extracorporeal Shockwave Therapy for Diabetes Related Foot Ulcer Healing.

International wound journal·2026
Same author

Extracorporeal Shockwave Therapy for Diabetes Related Foot Ulcers: A Pilot Three-Arm Double-Blinded Randomised Controlled Trial.

International wound journal·2025
Same author

Renal impairment risk in Indigenous and non-Indigenous people who take HIV pre-exposure prophylaxis (PrEP): a retrospective cohort study.

Sexual health·2025
Same author

A Pilot Three Arm Randomised Controlled Trial and Qualitative Study of Extracorporeal Shockwave Therapy for Diabetic Foot Ulcer Healing (SOLEFUL): A Study Protocol.

International wound journal·2025
Same author

The development of an EU-wide nutrition and physical activity expert knowledge base to support a personalised mobile application across various EU population groups.

Nutrition bulletin·2024
Same author

The use of babosa (Aloe vera) in treating burns: a literature review.

Brazilian journal of biology = Revista brasleira de biologia·2021

Area of Science:

  • Cell Biology
  • Pharmacology
  • Genetics

Background:

  • Cystic fibrosis (CF) is characterized by defective protein secretion in airway glands, leading to viscous mucus.
  • The cystic fibrosis transmembrane conductance regulator (CFTR) is crucial for secreting mucins and serous proteins.

Purpose of the Study:

  • To pharmacologically correct CFTR defects in airway gland cells to address viscous mucus in CF.
  • To investigate strategies including direct CFTR activation, bypass of CFTR pathways, and DeltaF508-CFTR trafficking.

Main Methods:

  • Tested compounds related to IBMX, including phosphodiesterase inhibitors and adenosine receptor antagonists (CPT, CPX).
  • Utilized CFTR antibody-inhibited submandibular gland cells and DeltaF508/DeltaF508-CFTR nasal gland cells.
  • Investigated glycoprotein secretion in Calu-3 cells and DeltaF508-CFTR trafficking using confocal imaging.

Related Experiment Videos

Main Results:

  • Compounds CPT and CPX corrected defective beta-adrenergic stimulation of mucin secretion in submandibular cells.
  • CPT also corrected lactoferrin secretion in nasal gland cells with DeltaF508-CFTR mutation.
  • Pharmacological correction occurred without excessive cyclic AMP increase and did not require enhanced CFTR Cl(-) channel activity.
  • Confocal imaging revealed partialDeltaF508-CFTR colocalization with CD59 at the apical membrane, but significant mislocalization within the cell.

Conclusions:

  • Pharmacological correction of CFTR-mediated protein secretion is achievable.
  • These findings suggest a promising avenue for developing rational drug therapies for cystic fibrosis patients.
  • The mechanism involves direct CFTR interaction, not solely cyclic AMP elevation or increased channel activity.